Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances toward precision medicine for bipolar disorder: mechanisms & molecules
Stephen J. Haggarty, Rakesh Karmacharya, Roy H. Perlis
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 168-185
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites
Francesco Bartoli, Błażej Misiak, Tommaso Callovini, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3419-3429
Closed Access | Times Cited: 74
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Yinrou Huang, Mengke Zhao, Xuemei Chen, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 858-858
Open Access | Times Cited: 61
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Analı́a Bortolozzi, Giovanna Fico, Michael Berk, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 323-357
Open Access | Times Cited: 8
From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care
Masaru Tanaka
Biomedicines (2025) Vol. 13, Iss. 1, pp. 167-167
Open Access | Times Cited: 1
A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania
Ann L. Sharpley, Clare Williams, Adele A Holder, et al.
Psychopharmacology (2020) Vol. 237, Iss. 12, pp. 3773-3782
Open Access | Times Cited: 52
Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview
Enrique L. M. Ochoa
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 1, pp. 85-97
Closed Access | Times Cited: 42
A novel murine model of mania
Xinyu Li, Binjie Chen, Dianjun Zhang, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 3044-3054
Open Access | Times Cited: 18
Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings
Ming Li, Tao Li, Xiao Xiao, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 7, pp. 2927-2939
Closed Access | Times Cited: 27
Advanced methods and implementations for the meta-analyses of animal models: Current practices and future recommendations
Yefeng Yang, Malcolm Macleod, Jinming Pan, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 146, pp. 105016-105016
Open Access | Times Cited: 25
Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity
Dipashree Chatterjee, Jean‐Martin Beaulieu
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 22
T cells: an emerging cast of roles in bipolar disorder
Zhenni Chen, Yiran Huang, Bingqi Wang, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review
Rafał Marecki, Joanna Kałuska, Agata Kolanek, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
Bipolar Disorders in Saudi Arabia: What Do We Know So Far?
Ahmad H. Almadani, Ahmad N. AlHadi, Buthainah D. Aldawood, et al.
Saudi Journal of Medicine and Medical Sciences (2025) Vol. 13, Iss. 1, pp. 1-6
Open Access
Exploring Lithium Concentrations in Maternal blood, Amniotic fluid and Umbilical cord blood: Babies Born to Mothers Treated with Lithium Carbonate for Bipolar Disorder
Celine Lindqvist Neergaard, Frederikke Lihme, Rie Lambæk Mikkelsen, et al.
Danish Journal of Obstetrics and Gynaecology (2025) Vol. 3, Iss. 1, pp. 34-41
Closed Access
Characterization of the Molecular Mechanisms Underlying Lurasidone‐Induced Acute Manic Episodes in Bipolar Depression: A Network Pharmacology and Molecular Docking Approach
Chao Li, Lei Yang, Qiuyu Zhang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 4
Open Access
Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
Francesco Bartoli, Daniele Cavaleri, Bianca Bachi, et al.
Journal of Psychiatric Research (2021) Vol. 143, pp. 230-238
Closed Access | Times Cited: 29
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
Sourav Khanra, P. Hemachandra Reddy, Anna Giménez‐Palomo, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3231-3242
Open Access | Times Cited: 11
Lived Experience–Led Research Agenda to Address Early Death in People With a Diagnosis of a Serious Mental Illness
Karen L. Fortuna, Stephanie Lebby, Pamela Geiger, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2315479-e2315479
Open Access | Times Cited: 9
Olink proteomics analysis uncovers inflammatory proteins in patients with different states of bipolar disorder
Fangming Xu, Yu Su, Xiaobo Wang, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111816-111816
Open Access | Times Cited: 3
Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trials
Lingzhuo Kong, Huaizhi Wang, Ning Yan, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102581-102581
Open Access | Times Cited: 3
Safranal alleviates pentetrazole-induced epileptic seizures in mice by inhibiting the NF-κB signaling pathway and mitochondrial-dependent apoptosis through GSK-3β inactivation
Jieping Yan, Tingting Li, Kaiyue Ji, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118408-118408
Open Access | Times Cited: 3
Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy
Gabriela Hjell, Jaroslav Rokicki, Attila Szabó, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
Rodrigo Machado‐Vieira, Alan C. Courtes, Carlos A. Zarate, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Functional genomic analysis delineates regulatory mechanisms of GWAS-identified bipolar disorder risk variants
Rui Chen, Zhihui Yang, Jiewei Liu, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top